Effect of dronedarone on Na+, Ca2+ and HCN channels-Reference-Cited by-同舟云学术

Effect of dronedarone on Na+, Ca2+ and HCN channels

Published:2011-01-29 Issue:4 Volume:383 Page:347-356
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmied Arch Pharmacol

Author:

Bogdan Roman,Goegelein Heinz,Ruetten Hartmut

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00210-011-0599-9.pdf

Reference41 articles.

1. Baruscotti M, Bucchi A, DiFrancesco D (2005) Physiology and pharmacology of the cardiac pacemaker ("funny") current. Pharmacol Ther 107:59–79

2. Bogdan R, Goegelein H, Ruetten H (2009) Viable heart slices: action potential recordings from atrial and ventricular tissues. Acta Physiol 195(suppl 669):64

3. Bucchi A, Tognati A, Milanesi R, Baruscotti M, DiFrancesco D (2006) Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels. J Physiol 572:335–346

4. Burashnikov A, Antzelevitch C (2009) Atrial-selective sodium channel block for the treatment of atrial fibrillation. Expert Opin Emerg Drugs 14:233–249

5. Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C (2007) Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation 116:1449–1457

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the interplay between extracellular pH and Dronedarone's pharmacological effects on cardiac function;European Journal of Pharmacology;2024-11

2. Depolarization of the atrial resting membrane potential as an approach to enhance the anti–atrial fibrillation efficacy of sodium channel blockers;Heart Rhythm;2021-07

3. Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone;Heart Rhythm;2021-07

4. Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option;Frontiers in Pharmacology;2021-03-04

5. An exploratory analysis of effects of poyendarone, a deuterated analogue of dronedarone, on the canine model of paroxysmal atrial fibrillation;Naunyn-Schmiedeberg's Archives of Pharmacology;2021-01-11